O	O	0	9	Molecular	Molecular	B-NP	JJ	O	2	NMOD	O
O	O	10	20	mechanisms	mechanism	I-NP	NNS	O	0	ROOT	O
O	O	21	23	of	of	B-PP	IN	O	2	NMOD	O
O	O	24	30	anoxia	anoxia	B-NP	NN	O	10	NMOD	O
O	O	30	31	/	/	B-NP	SYM	O	10	NMOD	O
O	O	31	44	reoxygenation	reoxygenation	I-NP	NN	O	10	NMOD	O
O	O	44	45	-	-	B-NP	HYPH	O	10	NMOD	O
O	O	45	52	induced	induce	I-NP	VBN	O	10	NMOD	O
O	O	53	63	neutrophil	neutrophil	I-NP	NN	O	10	NMOD	O
O	O	64	73	adherence	adherence	I-NP	NN	O	3	PMOD	O
O	O	74	76	to	to	B-PP	TO	O	10	NMOD	O
O	O	77	85	cultured	culture	B-NP	VBN	B-cell_line	14	NMOD	B-cell_line
O	O	86	97	endothelial	endothelial	I-NP	JJ	I-cell_line	14	NMOD	I-cell_line
O	O	98	103	cells	cell	I-NP	NNS	I-cell_line	11	PMOD	I-cell_line
O	O	103	104	.	.	O	.	O	2	P	O

O	O	106	109	The	The	B-NP	DT	O	2	NMOD	O
O	O	110	120	objectives	objective	I-NP	NNS	O	6	SUB	O
O	O	121	123	of	of	B-PP	IN	O	2	NMOD	O
O	O	124	128	this	this	B-NP	DT	O	5	NMOD	O
O	O	129	134	study	study	I-NP	NN	O	3	PMOD	O
O	O	135	139	were	be	B-VP	VBD	O	0	ROOT	O
O	O	140	142	to	to	B-PP	TO	O	11	VMOD	O
O	O	143	144	(	(	O	(	O	9	DEP	O
O	O	144	145	1	1	B-NP	CD	O	11	VMOD	O
O	O	145	146	)	)	O	)	O	9	DEP	O
O	O	147	156	determine	determine	B-VP	VBP	O	6	PRD	O
O	O	157	160	the	the	B-NP	DT	O	14	NMOD	O
O	O	161	165	time	time	I-NP	NN	O	14	NMOD	O
O	O	166	172	course	course	I-NP	NN	O	11	OBJ	O
O	O	173	175	of	of	B-PP	IN	O	14	NMOD	O
O	O	176	186	neutrophil	neutrophil	B-NP	NN	B-cell_type	17	NMOD	B-cell_type
O	O	187	195	adhesion	adhesion	I-NP	NN	O	15	PMOD	O
O	O	196	198	to	to	B-PP	TO	O	17	NMOD	O
O	O	199	209	monolayers	monolayer	B-NP	NNS	O	18	PMOD	O
O	O	210	212	of	of	B-PP	IN	O	19	NMOD	O
O	O	213	218	human	human	B-NP	JJ	B-cell_line	25	NMOD	B-cell_line
O	O	219	228	umbilical	umbilical	I-NP	JJ	I-cell_line	25	NMOD	I-cell_line
O	O	229	233	vein	vein	I-NP	NN	I-cell_line	25	NMOD	I-cell_line
O	O	234	245	endothelial	endothelial	I-NP	JJ	I-cell_line	25	NMOD	I-cell_line
O	O	246	251	cells	cell	I-NP	NNS	I-cell_line	20	PMOD	I-cell_line
O	O	252	253	(	(	O	(	O	28	DEP	O
O	O	253	259	HUVECs	HUVEC	B-NP	NNS	B-cell_line	28	DEP	B-cell_line
O	O	259	260	)	)	O	)	O	25	NMOD	O
O	O	261	265	that	that	B-NP	WDT	O	19	NMOD	O
O	O	266	270	were	be	B-VP	VBD	O	29	SBAR	O
O	O	271	278	exposed	expose	I-VP	VBN	O	30	VC	O
O	O	279	281	to	to	B-PP	TO	O	31	VMOD	O
O	O	282	284	60	60	B-NP	CD	O	34	NMOD	O
O	O	285	292	minutes	minute	I-NP	NNS	O	32	PMOD	O
O	O	293	295	of	of	B-PP	IN	O	34	NMOD	O
O	O	296	302	anoxia	anoxia	B-NP	NN	O	35	PMOD	O
O	O	303	311	followed	follow	B-VP	VBN	O	34	NMOD	O
O	O	312	314	by	by	B-PP	IN	O	37	VMOD	O
O	O	315	317	30	30	B-NP	CD	O	41	AMOD	O
O	O	318	320	to	to	I-NP	TO	O	41	AMOD	O
O	O	321	324	600	600	I-NP	CD	O	42	NMOD	O
O	O	325	332	minutes	minute	I-NP	NNS	O	38	PMOD	O
O	O	333	335	of	of	B-PP	IN	O	42	NMOD	O
O	O	336	349	reoxygenation	reoxygenation	B-NP	NN	O	43	PMOD	O
O	O	350	353	and	and	O	CC	O	11	VMOD	O
O	O	354	355	(	(	B-LST	(	O	47	DEP	O
O	O	355	356	2	2	I-LST	LS	O	49	VMOD	O
O	O	356	357	)	)	O	)	O	47	DEP	O
O	O	358	364	define	define	B-VP	VB	O	11	VMOD	O
O	O	365	368	the	the	B-NP	DT	O	51	NMOD	O
O	O	369	379	mechanisms	mechanism	I-NP	NNS	O	49	OBJ	O
O	O	380	391	responsible	responsible	B-ADJP	JJ	O	51	NMOD	O
O	O	392	395	for	for	B-PP	IN	O	52	AMOD	O
O	O	396	400	both	both	O	CC	O	65	NMOD	O
O	O	401	404	the	the	B-NP	DT	O	65	NMOD	O
O	O	405	410	early	early	I-NP	JJ	O	65	NMOD	O
O	O	411	412	(	(	O	(	O	59	DEP	O
O	O	412	419	minutes	minute	B-NP	NNS	O	59	DEP	O
O	O	419	420	)	)	O	)	O	56	AMOD	O
O	O	421	424	and	and	O	CC	O	65	NMOD	O
O	O	425	429	late	late	B-NP	JJ	O	65	NMOD	O
O	O	430	431	(	(	I-NP	(	O	64	DEP	O
O	O	431	436	hours	hour	I-NP	NNS	O	64	DEP	O
O	O	436	437	)	)	O	)	O	61	AMOD	O
O	O	438	453	hyperadhesivity	hyperadhesivity	B-NP	NN	O	53	PMOD	O
O	O	454	456	of	of	B-PP	IN	O	65	NMOD	O
O	O	457	467	postanoxic	postanoxic	B-NP	JJ	B-cell_line	68	NMOD	B-cell_line
O	O	468	474	HUVECs	HUVEC	I-NP	NNS	I-cell_line	66	PMOD	I-cell_line
O	O	475	477	to	to	B-PP	TO	O	65	NMOD	O
O	O	478	483	human	human	B-NP	JJ	B-cell_type	71	NMOD	B-cell_type
O	O	484	495	neutrophils	neutrophil	I-NP	NNS	I-cell_type	69	PMOD	I-cell_type
O	O	495	496	.	.	O	.	O	6	P	O

O	O	497	500	The	The	B-NP	DT	O	2	NMOD	O
O	O	501	508	results	result	I-NP	NNS	O	4	SUB	O
O	O	509	516	clearly	clearly	B-ADVP	RB	O	4	VMOD	O
O	O	517	528	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	529	533	that	that	B-SBAR	IN	O	4	VMOD	O
O	O	534	540	anoxia	anoxia	B-NP	NN	O	5	SBAR	O
O	O	540	541	/	/	O	SYM	O	6	NMOD	O
O	O	541	554	reoxygenation	reoxygenation	B-NP	NN	O	14	SUB	O
O	O	555	556	(	(	O	(	O	13	DEP	O
O	O	556	557	A	A	B-NP	NN	O	12	NMOD	O
O	O	557	558	/	/	I-NP	SYM	O	12	NMOD	O
O	O	558	559	R	R	I-NP	NN	O	13	DEP	O
O	O	559	560	)	)	O	)	O	8	NMOD	O
O	O	561	566	leads	lead	B-VP	VBZ	O	7	SBAR	O
O	O	567	569	to	to	B-PP	TO	O	14	VMOD	O
O	O	570	571	a	a	B-NP	DT	O	18	NMOD	O
O	O	572	580	biphasic	biphasic	I-NP	JJ	O	18	NMOD	O
O	O	581	589	increase	increase	I-NP	NN	O	15	PMOD	O
O	O	590	592	in	in	B-PP	IN	O	18	NMOD	O
O	O	593	603	neutrophil	neutrophil	B-NP	NN	B-cell_type	21	NMOD	B-cell_type
O	O	604	612	adhesion	adhesion	I-NP	NN	O	19	PMOD	O
O	O	613	615	to	to	B-PP	TO	O	21	NMOD	O
O	O	616	622	HUVECs	HUVEC	B-NP	NNS	B-cell_line	22	PMOD	B-cell_line
O	O	622	623	,	,	O	,	O	14	P	O
O	O	624	628	with	with	B-PP	IN	O	14	VMOD	O
O	O	629	633	peak	peak	B-NP	NN	O	27	NMOD	O
O	O	634	643	responses	response	I-NP	NNS	O	28	SUB	O
O	O	644	653	occurring	occur	B-VP	VBG	O	25	PMOD	O
O	O	654	656	at	at	B-PP	IN	O	28	VMOD	O
O	O	657	659	30	30	B-NP	CD	O	31	NMOD	O
O	O	660	667	minutes	minute	I-NP	NNS	O	38	NMOD	O
O	O	668	669	(	(	O	(	O	35	DEP	O
O	O	669	674	phase	phase	B-NP	NN	O	35	DEP	O
O	O	675	676	1	1	I-NP	CD	O	33	NMOD	O
O	O	676	677	)	)	O	)	O	31	NMOD	O
O	O	678	681	and	and	O	CC	O	38	NMOD	O
O	O	682	685	240	240	B-NP	CD	O	38	NMOD	O
O	O	686	693	minutes	minute	I-NP	NNS	O	29	PMOD	O
O	O	694	695	(	(	O	(	O	42	DEP	O
O	O	695	700	phase	phase	B-NP	NN	O	42	DEP	O
O	O	701	702	2	2	I-NP	CD	O	40	NMOD	O
O	O	702	703	)	)	O	)	O	38	NMOD	O
O	O	704	709	after	after	B-PP	IN	O	38	NMOD	O
O	O	710	723	reoxygenation	reoxygenation	B-NP	NN	O	43	PMOD	O
O	O	723	724	.	.	O	.	O	4	P	O

O	O	725	735	Oxypurinol	Oxypurinol	B-NP	NN	O	3	NMOD	O
O	O	736	739	and	and	I-NP	CC	O	3	NMOD	O
T1	B-Protein	740	748	catalase	catalase	I-NP	NN	B-protein	4	SUB	B-protein
O	O	749	758	inhibited	inhibit	B-VP	VBD	O	0	ROOT	O
O	O	759	764	phase	phase	B-NP	NN	O	8	NMOD	O
O	O	764	765	-	-	B-NP	HYPH	O	8	NMOD	O
O	O	765	766	1	1	I-NP	CD	O	8	NMOD	O
O	O	767	775	adhesion	adhesion	I-NP	NN	O	4	OBJ	O
O	O	775	776	,	,	O	,	O	4	P	O
O	O	777	787	suggesting	suggest	B-VP	VBG	O	4	VMOD	O
O	O	788	789	a	a	B-NP	DT	O	12	NMOD	O
O	O	790	794	role	role	I-NP	NN	O	10	OBJ	O
O	O	795	798	for	for	B-PP	IN	O	12	NMOD	O
T2	B-Protein	799	807	xanthine	xanthine	B-NP	NN	B-protein	15	NMOD	B-protein
T2	I-Protein	808	815	oxidase	oxidase	I-NP	NN	I-protein	17	NMOD	I-protein
O	O	816	819	and	and	I-NP	CC	O	17	NMOD	O
O	O	820	824	H2O2	H2O2	I-NP	NN	O	13	PMOD	O
O	O	824	825	.	.	O	.	O	4	P	O

O	O	826	828	In	In	B-PP	IN	O	10	VMOD	O
O	O	829	839	comparison	comparison	B-NP	NN	O	1	PMOD	O
O	O	839	840	,	,	O	,	O	10	P	O
O	O	841	849	platelet	platelet	B-NP	NN	B-protein	6	NMOD	B-protein
O	O	850	860	activating	activating	I-NP	NN	I-protein	6	NMOD	I-protein
O	O	861	867	factor	factor	I-NP	NN	I-protein	10	SUB	I-protein
O	O	868	869	(	(	O	(	O	9	DEP	O
O	O	869	872	PAF	PAF	B-NP	NN	B-protein	9	DEP	B-protein
O	O	872	873	)	)	O	)	O	6	NMOD	O
O	O	874	885	contributed	contribute	B-VP	VBD	O	0	ROOT	O
O	O	886	888	to	to	B-PP	TO	O	10	VMOD	O
O	O	889	893	both	both	B-NP	DT	O	13	NMOD	O
O	O	894	900	phases	phase	I-NP	NNS	O	11	PMOD	O
O	O	901	903	of	of	B-PP	IN	O	13	NMOD	O
O	O	904	914	neutrophil	neutrophil	B-NP	NN	B-cell_type	16	NMOD	B-cell_type
O	O	915	923	adhesion	adhesion	I-NP	NN	O	14	PMOD	O
O	O	923	924	.	.	O	.	O	10	P	O

O	O	925	929	Anti	Anti	B-NP	AFX	O	7	NMOD	O
O	O	929	930	-	-	I-NP	HYPH	B-protein	5	NMOD	B-protein
T3	B-Protein	930	943	intercellular	intercellular	I-NP	JJ	I-protein	5	NMOD	I-protein
T3	I-Protein	944	952	adhesion	adhesion	I-NP	NN	I-protein	5	NMOD	I-protein
T3	I-Protein	953	961	molecule	molecule	I-NP	NN	I-protein	7	NMOD	I-protein
T3	I-Protein	961	962	-	-	B-NP	HYPH	O	7	P	O
T3	I-Protein	962	963	1	1	I-NP	CD	O	27	SUB	O
O	O	964	965	(	(	O	(	O	12	DEP	O
T4	B-Protein	965	969	ICAM	ICAM	B-NP	NN	B-protein	10	NMOD	B-protein
T4	I-Protein	969	970	-	-	B-NP	HYPH	I-protein	12	DEP	I-protein
T4	I-Protein	970	971	1	1	I-NP	CD	I-protein	10	NMOD	I-protein
O	O	971	972	)	)	O	)	O	7	NMOD	O
O	O	973	976	and	and	O	CC	O	19	NMOD	O
O	O	977	981	anti	anti	B-NP	AFX	O	19	NMOD	O
O	O	981	982	-	-	B-NP	HYPH	B-protein	19	NMOD	B-protein
T5	B-Protein	982	983	P	P	I-NP	NN	I-protein	19	NMOD	I-protein
T5	I-Protein	983	984	-	-	I-NP	HYPH	I-protein	19	NMOD	I-protein
T5	I-Protein	984	992	selectin	selectin	I-NP	NN	I-protein	19	NMOD	I-protein
O	O	993	1003	antibodies	antibody	I-NP	NNS	I-protein	7	NMOD	I-protein
O	O	1004	1005	(	(	O	(	O	26	DEP	O
O	O	1005	1015	monoclonal	monoclonal	B-NP	JJ	B-protein	22	NMOD	B-protein
O	O	1016	1026	antibodies	antibody	I-NP	NNS	I-protein	26	DEP	I-protein
O	O	1027	1028	[	[	O	(	O	25	DEP	O
O	O	1028	1032	mAbs	mAb	B-NP	NNS	B-protein	25	DEP	B-protein
O	O	1032	1033	]	]	O	)	O	22	NMOD	O
O	O	1033	1034	)	)	O	)	O	7	NMOD	O
O	O	1035	1045	attenuated	attenuate	B-VP	VBD	O	0	ROOT	O
O	O	1046	1051	phase	phase	B-NP	NN	O	32	NMOD	O
O	O	1051	1052	-	-	B-NP	HYPH	O	32	NMOD	O
O	O	1052	1053	1	1	I-NP	CD	O	32	NMOD	O
O	O	1054	1064	neutrophil	neutrophil	I-NP	NN	B-cell_type	32	NMOD	B-cell_type
O	O	1065	1073	adhesion	adhesion	I-NP	NN	O	27	OBJ	O
O	O	1073	1074	,	,	O	,	O	32	P	O
O	O	1075	1085	consistent	consistent	B-ADJP	JJ	O	32	NMOD	O
O	O	1086	1090	with	with	B-PP	IN	O	34	AMOD	O
O	O	1091	1096	roles	role	B-NP	NNS	O	35	PMOD	O
O	O	1097	1100	for	for	B-PP	IN	O	36	NMOD	O
O	O	1101	1115	constitutively	constitutively	B-NP	RB	O	39	AMOD	O
O	O	1116	1125	expressed	express	I-NP	VBN	O	40	NMOD	O
T6	B-Protein	1126	1130	ICAM	ICAM	I-NP	NN	B-protein	46	NMOD	B-protein
T6	I-Protein	1130	1131	-	-	B-NP	HYPH	O	46	NMOD	O
T6	I-Protein	1131	1132	1	1	I-NP	CD	O	46	NMOD	O
O	O	1133	1136	and	and	O	CC	O	46	NMOD	O
O	O	1137	1145	enhanced	enhance	B-VP	VBN	O	46	NMOD	O
O	O	1146	1153	surface	surface	B-NP	NN	O	46	NMOD	O
O	O	1154	1164	expression	expression	I-NP	NN	O	37	PMOD	O
O	O	1165	1167	of	of	B-PP	IN	O	46	NMOD	O
O	O	1168	1177	preformed	preforme	B-NP	VBN	O	51	NMOD	O
T7	B-Protein	1178	1179	P	P	I-NP	NN	B-protein	51	NMOD	B-protein
T7	I-Protein	1179	1180	-	-	I-NP	HYPH	I-protein	51	NMOD	I-protein
T7	I-Protein	1180	1188	selectin	selectin	I-NP	NN	I-protein	47	PMOD	I-protein
O	O	1188	1189	.	.	O	.	O	27	P	O

O	O	1190	1195	Phase	Phase	B-NP	NN	O	5	NMOD	O
O	O	1195	1196	-	-	I-NP	HYPH	O	1	P	O
O	O	1196	1197	2	2	I-NP	CD	O	5	NMOD	O
O	O	1198	1208	neutrophil	neutrophil	I-NP	NN	B-cell_type	5	NMOD	B-cell_type
O	O	1209	1217	adhesion	adhesion	I-NP	NN	O	6	SUB	O
O	O	1218	1221	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1222	1232	attenuated	attenuate	I-VP	VBN	O	6	VC	O
O	O	1233	1235	by	by	B-PP	IN	O	7	VMOD	O
O	O	1236	1238	an	an	B-NP	DT	O	15	NMOD	O
O	O	1239	1243	anti	anti	I-NP	AFX	O	15	NMOD	O
O	O	1243	1244	-	-	I-NP	HYPH	O	15	NMOD	O
T8	B-Protein	1244	1245	E	E	I-NP	NN	B-protein	15	NMOD	B-protein
T8	I-Protein	1245	1246	-	-	I-NP	HYPH	I-protein	15	NMOD	I-protein
T8	I-Protein	1246	1254	selectin	selectin	I-NP	NN	I-protein	15	NMOD	I-protein
O	O	1255	1258	mAb	mAb	I-NP	NN	I-protein	8	PMOD	I-protein
O	O	1258	1259	,	,	O	,	O	6	P	O
O	O	1260	1270	indicating	indicate	B-VP	VBG	O	6	VMOD	O
O	O	1271	1272	a	a	B-NP	DT	O	20	NMOD	O
O	O	1273	1281	dominant	dominant	I-NP	JJ	O	20	NMOD	O
O	O	1282	1286	role	role	I-NP	NN	O	17	OBJ	O
O	O	1287	1289	of	of	B-PP	IN	O	20	NMOD	O
O	O	1290	1294	this	this	B-NP	DT	O	24	NMOD	O
O	O	1295	1303	adhesion	adhesion	I-NP	NN	B-protein	24	NMOD	B-protein
O	O	1304	1312	molecule	molecule	I-NP	NN	I-protein	21	PMOD	I-protein
O	O	1313	1315	in	in	B-PP	IN	O	20	NMOD	O
O	O	1316	1319	the	the	B-NP	DT	O	29	NMOD	O
O	O	1320	1324	late	late	I-NP	JJ	O	29	NMOD	O
O	O	1325	1330	phase	phase	I-NP	NN	O	29	NMOD	O
O	O	1331	1339	response	response	I-NP	NN	O	25	PMOD	O
O	O	1339	1340	.	.	O	.	O	6	P	O

O	O	1341	1353	Pretreatment	Pretreatment	B-NP	NN	O	29	SUB	O
O	O	1354	1358	with	with	B-PP	IN	O	1	NMOD	O
O	O	1359	1370	actinomycin	actinomycin	B-NP	NN	O	4	NMOD	O
O	O	1371	1372	D	D	I-NP	NN	O	6	NMOD	O
O	O	1373	1376	and	and	I-NP	CC	O	6	NMOD	O
O	O	1377	1390	cycloheximide	cycloheximide	I-NP	NN	O	2	PMOD	O
O	O	1391	1393	or	or	B-PP	CC	O	2	PMOD	O
O	O	1394	1398	with	with	B-PP	IN	O	2	PMOD	O
O	O	1399	1408	competing	compete	B-NP	VBG	O	12	NMOD	O
T13,T14	B-Entity,B-Entity	1409	1411	ds	d	I-NP	NNS	O	12	NMOD	O
T13,T14	I-Entity,I-Entity	1411	1412	-	-	O	HYPH	O	12	NMOD	O
T13,T14	I-Entity,I-Entity	1412	1428	oligonucleotides	oligonucleotide	B-NP	NNS	O	8	PMOD	O
T13	I-Entity	1429	1439	containing	contain	B-VP	VBG	O	12	NMOD	O
O	O	1440	1443	the	the	B-NP	DT	O	22	NMOD	O
O	O	1444	1451	nuclear	nuclear	I-NP	JJ	B-protein	22	NMOD	B-protein
O	O	1452	1458	factor	factor	I-NP	NN	I-protein	22	NMOD	I-protein
O	O	1458	1459	-	-	B-NP	HYPH	I-protein	22	P	I-protein
O	O	1459	1464	kappa	kappa	I-NP	NN	I-protein	19	NMOD	I-protein
O	O	1465	1466	B	B	I-NP	NN	I-protein	22	NMOD	I-protein
O	O	1467	1469	or	or	O	CC	I-protein	22	NMOD	I-protein
T9	B-Protein	1470	1479	activator	activator	B-NP	NN	I-protein	22	NMOD	I-protein
T9	I-Protein	1480	1487	protein	protein	I-NP	NN	I-protein	27	NMOD	I-protein
T9	I-Protein	1487	1488	-	-	B-NP	HYPH	O	27	NMOD	O
T9	I-Protein	1488	1489	1	1	I-NP	CD	O	27	NMOD	O
T15	B-Entity	1490	1497	cognate	cognate	I-NP	JJ	B-DNA	27	NMOD	B-DNA
T15	I-Entity	1498	1501	DNA	DNA	I-NP	NN	I-DNA	27	NMOD	I-DNA
T15	I-Entity	1502	1511	sequences	sequence	I-NP	NNS	I-DNA	13	OBJ	I-DNA
O	O	1512	1525	significantly	significantly	B-ADVP	RB	O	29	VMOD	O
O	O	1526	1536	attenuated	attenuate	B-VP	VBD	O	0	ROOT	O
O	O	1537	1542	phase	phase	B-NP	NN	O	33	NMOD	O
O	O	1542	1543	-	-	O	HYPH	O	33	NMOD	O
O	O	1543	1544	2	2	B-NP	CD	O	33	NMOD	O
O	O	1545	1553	response	response	I-NP	NN	O	29	OBJ	O
O	O	1553	1554	,	,	O	,	O	29	P	O
O	O	1555	1565	suggesting	suggest	B-VP	VBG	O	29	VMOD	O
O	O	1566	1567	a	a	B-NP	DT	O	37	NMOD	O
O	O	1568	1572	role	role	I-NP	NN	O	35	OBJ	O
O	O	1573	1576	for	for	B-PP	IN	O	37	NMOD	O
O	O	1577	1579	de	de	B-NP	FW	O	40	AMOD	O
O	O	1580	1584	novo	novo	I-NP	FW	O	42	NMOD	O
O	O	1585	1598	macromolecule	macromolecule	I-NP	NN	O	42	NMOD	O
O	O	1599	1608	synthesis	synthesis	I-NP	NN	O	38	PMOD	O
O	O	1608	1609	.	.	O	.	O	29	P	O

O	O	1610	1617	Surface	Surface	B-NP	NN	O	2	NMOD	O
O	O	1618	1628	expression	expression	I-NP	NN	O	15	NMOD	O
O	O	1629	1631	of	of	B-PP	IN	O	2	NMOD	O
T10	B-Protein	1632	1636	ICAM	ICAM	B-NP	NN	B-protein	5	NMOD	B-protein
T10	I-Protein	1636	1637	-	-	B-NP	HYPH	I-protein	10	NMOD	I-protein
T10	I-Protein	1637	1638	1	1	I-NP	CD	I-protein	5	NMOD	I-protein
O	O	1638	1639	,	,	O	,	O	5	P	O
T11	B-Protein	1640	1641	P	P	B-NP	NN	B-protein	10	NMOD	B-protein
T11	I-Protein	1641	1642	-	-	I-NP	HYPH	I-protein	10	NMOD	I-protein
T11	I-Protein	1642	1650	selectin	selectin	I-NP	NN	I-protein	3	PMOD	I-protein
O	O	1650	1651	,	,	O	,	O	15	P	O
O	O	1652	1655	and	and	O	CC	O	15	NMOD	O
T12	B-Protein	1656	1657	E	E	B-NP	NN	B-protein	15	NMOD	B-protein
T12	I-Protein	1657	1658	-	-	B-NP	HYPH	I-protein	15	NMOD	I-protein
T12	I-Protein	1658	1666	selectin	selectin	I-NP	NN	I-protein	18	SUB	I-protein
O	O	1667	1669	on	on	B-PP	IN	O	15	NMOD	O
O	O	1670	1676	HUVECs	HUVEC	B-NP	NNS	B-cell_line	16	PMOD	B-cell_line
O	O	1677	1687	correlated	correlate	B-VP	VBD	O	0	ROOT	O
O	O	1688	1692	with	with	B-PP	IN	O	18	VMOD	O
O	O	1693	1696	the	the	B-NP	DT	O	29	NMOD	O
O	O	1697	1702	phase	phase	I-NP	NN	O	29	NMOD	O
O	O	1702	1703	-	-	B-NP	HYPH	O	29	P	O
O	O	1703	1704	1	1	I-NP	CD	O	29	NMOD	O
O	O	1705	1708	and	and	O	CC	O	29	NMOD	O
O	O	1709	1710	-	-	B-NP	SYM	O	29	NMOD	O
O	O	1710	1711	2	2	I-NP	CD	O	29	NMOD	O
O	O	1712	1722	neutrophil	neutrophil	I-NP	NN	B-cell_type	29	NMOD	B-cell_type
O	O	1723	1731	adhesion	adhesion	I-NP	NN	O	29	NMOD	O
O	O	1732	1741	responses	response	I-NP	NNS	O	19	PMOD	O
O	O	1741	1742	.	.	O	.	O	18	P	O

O	O	1743	1755	Collectively	Collectively	B-ADVP	RB	O	5	VMOD	O
O	O	1755	1756	,	,	O	,	O	5	P	O
O	O	1757	1762	these	these	B-NP	DT	O	4	NMOD	O
O	O	1763	1771	findings	finding	I-NP	NNS	O	5	SUB	O
O	O	1772	1780	indicate	indicate	B-VP	VBP	O	0	ROOT	O
O	O	1781	1785	that	that	B-SBAR	IN	O	5	VMOD	O
O	O	1786	1787	A	A	B-NP	NN	O	9	NMOD	O
O	O	1787	1788	/	/	I-NP	SYM	O	9	NMOD	O
O	O	1788	1789	R	R	I-NP	NN	B-protein	10	SUB	B-protein
O	O	1790	1797	elicits	elicit	B-VP	VBZ	O	6	SBAR	O
O	O	1798	1799	a	a	B-NP	DT	O	20	NMOD	O
O	O	1800	1803	two	two	I-NP	CD	O	20	NMOD	O
O	O	1803	1804	-	-	I-NP	HYPH	B-cell_type	15	NMOD	B-cell_type
O	O	1804	1809	phase	phase	I-NP	NN	I-cell_type	15	NMOD	I-cell_type
O	O	1810	1820	neutrophil	neutrophil	I-NP	NN	I-cell_type	20	NMOD	I-cell_type
O	O	1820	1821	-	-	B-NP	HYPH	O	20	NMOD	O
O	O	1821	1832	endothelial	endothelial	I-NP	JJ	O	20	NMOD	O
O	O	1833	1837	cell	cell	I-NP	NN	O	20	NMOD	O
O	O	1838	1846	adhesion	adhesion	I-NP	NN	O	20	NMOD	O
O	O	1847	1855	response	response	I-NP	NN	O	10	OBJ	O
O	O	1856	1860	that	that	B-NP	WDT	O	20	NMOD	O
O	O	1861	1869	involves	involve	B-VP	VBZ	O	21	SBAR	O
O	O	1870	1883	transcription	transcription	B-NP	NN	O	31	NMOD	O
O	O	1883	1884	-	-	O	HYPH	O	31	NMOD	O
O	O	1884	1895	independent	independent	B-NP	JJ	O	27	NMOD	O
O	O	1896	1899	and	and	I-NP	CC	O	27	NMOD	O
O	O	1900	1913	transcription	transcription	I-NP	NN	O	31	NMOD	O
O	O	1913	1914	-	-	B-NP	HYPH	O	31	NMOD	O
O	O	1914	1923	dependent	dependent	I-NP	JJ	O	31	NMOD	O
O	O	1924	1931	surface	surface	I-NP	NN	O	31	NMOD	O
O	O	1932	1942	expression	expression	I-NP	NN	O	22	OBJ	O
O	O	1943	1945	of	of	B-PP	IN	O	31	NMOD	O
O	O	1946	1955	different	different	B-NP	JJ	O	32	PMOD	O
O	O	1956	1967	endothelial	endothelial	I-NP	JJ	B-protein	37	NMOD	B-protein
O	O	1968	1972	cell	cell	I-NP	NN	I-protein	37	NMOD	I-protein
O	O	1973	1981	adhesion	adhesion	I-NP	NN	I-protein	37	NMOD	I-protein
O	O	1982	1991	molecules	molecule	I-NP	NNS	I-protein	33	NMOD	I-protein
O	O	1991	1992	.	.	O	.	O	5	P	O
